Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> JOHNSON & JOHNSON Latest News

1 HOUR AGO - Philadelphia Inquirer

A Must Read - Share

Drug sales bolster J&J's bottom line

The old wives' tale that you will catch a cold if you don't bundle up was formally laid to rest last week when Johnson & Johnson released its stellar first-quarter earnings.

Tags: Drug sales bolster J&J's bottom line,  Johnson & Johnson Latest News

22 HOURS AGO - TheStreet

A Must Read - Share

Excellent Earnings, Tough Audience, Surprises Among the Leaders: Jim Cramer's Best Blogs

NEW YORK (TheStreet) -- Jim Cramer fills his blog on RealMoney every day with his up-to-the-minute reactions to what's happening in the market and his legendary ahead-of-the-crowd ideas. This week he blogged on: how this earnings season is excellent despite the haters, and why utilities and oil stocks are top performers now. Click here for information on RealMoney, where you ...

Tags: Excellent Earnings, Tough Audience, Surprises Among the Leaders: Jim Cramer's Best Blogs,  Johnson & Johnson Latest News

APR 16, 2014 - TheStreet

A Must Read - Share

Jim Cramer's 'Mad Money' Recap: Don't Blame the Companies

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener. NEW YORK (TheStreet) -- There's plenty wrong with this market, Jim Cramer said on Mad Money Wednesday, but don't blame the companies -- they're part of the solution, not the problem. Cramer said he's tired of hearing how earnings have been "tepid" and revenue have been ...

Tags: Jim Cramer's 'Mad Money' Recap: Don't Blame the Companies,  Johnson & Johnson Latest News

APR 16, 2014 - TheStreet

A Must Read - Share

Will This Price Target Increase Help Johnson & Johnson (JNJ) Stock Today?

NEW YORK (TheStreet) -- Leerink increased its price target on Johnson & Johnson  to $110, increased its estimates and set an "outperform" rating. The firm cited solid pharma momentum as the reason for the increase. The stock was flat at $99.24 at 9:52 a.m. on Wednesday. Must Read: Warren Buffett's 10 Favorite Growth Stocks STOCKS TO BUY: TheStreet Quant Ratings has identified a ...

Tags: Will This Price Target Increase Help Johnson & Johnson (JNJ) Stock Today?,  Johnson & Johnson Latest News

APR 16, 2014 - Benzinga

A Must Read - Share

UPDATE: Deutsche Bank Reiterates on Johnson & Johnson as Defensive Stock

In a report published Wednesday, Deutsche Bank analyst Greg Poole reiterated a Hold rating on Johnson & Johnson (NYSE: JNJ), and raised the price target from $100.00 to $102.00. In the report, Deutsche Bank noted, “Q14 Sales and EPS Beat on Pharma; Maintain Hold.

Tags: UPDATE: Deutsche Bank Reiterates on Johnson & Johnson as Defensive Stock,  Johnson & Johnson Latest News